Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25208290 | 0.88 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3799373 | 0.86 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8932160 | 0.84 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2332056 | 0.83 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL31315826 | 0.83 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29433653 | 0.83 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8164294 | 0.81 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2824504 | 0.81 | CA12 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL14246707 | 0.81 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL15658832 | 0.81 | SMN1; SMN2 (0.48) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334371-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-8404915-B2 | 1) at least one diaryl-substituted diphosphine ligand; 2) a chromium metal precursor; and 3) optionally, one or more activators | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-8404915-B2 | 1) at least one diaryl-substituted diphosphine ligand; 2) a chromium metal precursor; and 3) optionally, one or more activators | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-8404915-B2 | 1) at least one diaryl-substituted diphosphine ligand; 2) a chromium metal precursor; and 3) optionally, one or more activators | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-8076524-B2 | Process for generating alpha olefin comonomers | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-12-13 | — | — | US | disclosed |
| US-20080058486-A1 | Phosphine Ligand-Metal Compositions, Complexes, and Catalysts For Ethylene Trimerizations | SYMYX TECHNOLOGIES INC. | 2008-03-06 | — | — | US | disclosed |
| WO-2007092136-A2 | PROCESS FOR GENERATING ALPHA OLEFIN COMONOMERS | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2007-08-16 | — | — | WO | disclosed |
| US-20070185360-A1 | Process for generating linear apha olefin comonomers | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185360-A1 | Process for generating linear apha olefin comonomers | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185362-A1 | Process for generating alpha olefin comonomers | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185362-A1 | Process for generating alpha olefin comonomers | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185361-A1 | In-line process for generating comonomer | EXXONMOBIL CHEMIAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070185361-A1 | In-line process for generating comonomer | EXXONMOBIL CHEMIAL PATENTS INC. | 2007-08-09 | — | — | US | disclosed |
| EP-0587050-B1 | Process for the preparation of an aromatic group substituted olefins from chloroaromatics | HOECHST AG (DE) | 1996-03-13 | — | — | EP | disclosed |
| EP-0587050-A1 | Process for the preparation of an aromatic group substituted olefins from chloroaromatics | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185360-A1 | Process for generating linear apha olefin comonomers | ACMSD, AGL, ACSL4 | CA1 3568/4885CA2 4432/4885CA7 2798/4885 |
| US-20070185361-A1 | In-line process for generating comonomer | ELL, SAMM50, AGL | CA1 4079/4885CA2 4091/4885CA7 2917/4885 |
| US-20070185362-A1 | Process for generating alpha olefin comonomers | ETFA, ETFB, SAMM50 | CA1 4259/4885CA2 4550/4885CA7 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.